Physician

Adam Scott Greenberg, M.D.

According to 2025 Medicare claims, Adam Greenberg, M.D. (NPI: 1932193729) practices dermatology in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Sarasota, FL. This provider's primary affiliated billing organization is SUNSHINE STATE DERMATOLOGY AND SKIN CANCER CENTER INC (NPI: 1164122347; TIN: 921321379) and primary practice location at 34287-1415.

Greenberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 785 traditional Medicare patients, billed 7,196 HCPCS/CPT codes, and received $901,545 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 899 prescription claims across 500 beneficiaries totaling $28,080 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 42 records totaling $1,008. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $93,237 and ending at $28,080. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,149	18,405	$1,076,712
2016	2,081	16,128	$902,905
2017	1,974	15,077	$975,449
2018	1,856	12,001	$1,106,233
2019	1,799	12,455	$1,122,821
2020	1,516	10,315	$1,078,486
2021	1,358	8,594	$1,030,955
2022	943	5,812	$743,017
2023	807	5,862	$632,346
2024	785	7,196	$901,545

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	495	896	$93,237
2016	546	1,008	$50,970
2017	636	1,201	$71,167
2018	658	1,215	$45,155
2019	655	1,228	$133,051
2020	774	1,386	$98,180
2021	732	1,261	$100,241
2022	628	1,046	$94,833
2023	523	870	$46,047
2024	500	899	$28,080

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	441	631	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	506	894	$62
11102	Biopsy of related skin growth, first growth	423	558	$46
17000	Destruction of precancer skin growth, 1 growth	411	679	$31
17003	Destruction of precancer skin growth, 2-14 growths	309	1,813	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	131	3,532	$9,280
Mupirocin	Mupirocin	326	5,893	$2,023
Clobetasol Propionate	Clobetasol Propionate	30	773	$1,281
Doxycycline Monohydrate	Doxycycline Monohydrate	83	814	$1,084
Gentamicin Sulfate	Gentamicin Sulfate	29	687	$818

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$1,008	SUN PHARMACEUTICAL INDUSTRIES INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Scott Greenberg, M.D.?

Tedicare shows public-source Medicare data for Adam Scott Greenberg, M.D. (NPI 1932193729), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Scott Greenberg, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Scott Greenberg, M.D.?

Adam Scott Greenberg, M.D. is linked to SUNSHINE STATE DERMATOLOGY AND SKIN CANCER CENTER INC (billing NPI 1164122347) in the available physician profile data.

Does Adam Scott Greenberg, M.D. have Open Payments data?

Adam Scott Greenberg, M.D. has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.